載入...
Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease
BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be...
Na minha lista:
| 發表在: | Can J Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Pulsus Group Inc
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4610647/ https://ncbi.nlm.nih.gov/pubmed/26125109 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|